Deutsche Bank Ag\ Verrica Pharmaceuticals Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Verrica Pharmaceuticals Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 591 shares of VRCA stock, worth $4,698. This represents 0.0% of its overall portfolio holdings.

Number of Shares

591

Previous 182,020 99.68%

Holding current value

$4,698

Previous $1.33 Million 99.7%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$7.95 - $7.95 $1.44 Million - $1.44 Million	-181,429 Reduced 99.68%	591 $4,000
Q2 2024 Aug 14, 2024	SELL	$5.89 - $9.56 $9,153 - $14,856	-1,554 Reduced 0.85%	182,020 $1.33 Million
Q1 2024 May 15, 2024	BUY	$4.74 - $6.81 $464,624 - $667,529	98,022 Added 114.58%	183,574 $1.09 Million
Q4 2023 Feb 14, 2024	BUY	$2.93 - $7.32 $250,333 - $625,406	85,438 Added 74945.61%	85,552 $626,000
Q3 2023 Nov 09, 2023	BUY	$3.75 - $7.46 $427 - $850	114 New	114 $0
Q2 2022 Aug 11, 2022	SELL	$1.81 - $8.93 $13,254 - $65,394	-7,323 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$7.59 - $9.49 $6,360 - $7,952	-838 Reduced 10.27%	7,323 $60,000
Q4 2021 Feb 11, 2022	BUY	$9.1 - $13.36 $3,822 - $5,611	420 Added 5.43%	8,161 $75,000
Q3 2021 Nov 04, 2021	SELL	$9.55 - $13.96 $3,027 - $4,425	-317 Reduced 3.93%	7,741 $97,000
Q2 2021 Aug 11, 2021	SELL	$9.77 - $15.33 $2,462 - $3,863	-252 Reduced 3.03%	8,058 $91,000
Q1 2021 May 13, 2021	SELL	$10.51 - $17.46 $7,914 - $13,147	-753 Reduced 8.31%	8,310 $125,000
Q4 2020 Feb 16, 2021	BUY	$7.41 - $12.63 $18,650 - $31,789	2,517 Added 38.45%	9,063 $104,000
Q3 2020 Nov 12, 2020	BUY	$6.16 - $10.3 $3,720 - $6,221	604 Added 10.16%	6,546 $51,000
Q2 2020 Aug 13, 2020	BUY	$9.02 - $15.12 $15,794 - $26,475	1,751 Added 41.78%	5,942 $65,000
Q1 2020 May 14, 2020	SELL	$7.14 - $16.86 $1,842 - $4,349	-258 Reduced 5.8%	4,191 $46,000
Q4 2019 Feb 14, 2020	BUY	$13.08 - $17.43 $11,588 - $15,442	886 Added 24.87%	4,449 $69,000
Q3 2019 Nov 14, 2019	SELL	$8.65 - $14.81 $54,823 - $93,865	-6,338 Reduced 64.01%	3,563 $51,000
Q2 2019 Aug 14, 2019	SELL	$7.1 - $11.62 $25,283 - $41,378	-3,561 Reduced 26.45%	9,901 $114,000
Q1 2019 May 15, 2019	BUY	$7.95 - $14.07 $46,746 - $82,731	5,880 Added 77.55%	13,462 $144,000
Q4 2018 Feb 14, 2019	SELL	$6.75 - $16.12 $37,752 - $90,159	-5,593 Reduced 42.45%	7,582 $61,000
Q3 2018 Dec 21, 2021	BUY	$13.94 - $19.88 $21,328 - $30,416	1,530 Added 13.14%	13,175 $214,000
Q3 2018 Nov 14, 2018	BUY	$13.94 - $19.88 $162,331 - $231,502	11,645 New	11,645 $188,000

Others Institutions Holding VRCA

# of Institutions

Shares Held

14.2M

Call Options Held

9.9K

Put Options Held

6.5K

View Full List

About Verrica Pharmaceuticals Inc.

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

More about VRCA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account